A breakthrough pricing agreement announced  in July at the 2018 International AIDS Conference will significantly reduce the cost of diagnostic testing for HIV/AIDS, hepatitis and cervical cancer for millions of people in low- and middle-income countries.

The agreement has been made between MedAccess, an initiative established by CDC to increase patient access to life-changing medical supplies in Africa and South Asia, and diagnostic testing manufacturer Hologic.

Read more